News Update: Pozen Shares Down 8.4% Ahead Of The FDA's Decision On An Arthritis Medication

Loading...

Sign in or sign up now!
Alert icon
Upgrade to the latest Flash Player for improved playback performance. Upgrade now or more info.
60 views
Loading...
Alert icon
Sign in or sign up now!
Alert icon

Uploaded by on Apr 30, 2010

Pozen Inc. (NASDAQ:POZN) shares fell 8.36% to $11.07 in early afternoon trading ahead of a decision from the FDA regarding an arthritis medication.

The FDA will issue a decision on whether to approve its new arthritis medication Vimovo by the end of Friday.

The drug was co-developed with AstraZeneca (NYSE:AZN). AstraZeneca shares are trading 0.50% lower at $44.12.

Category:

News & Politics

Tags:

License:

Standard YouTube License

  • likes, 0 dislikes

Link to this comment:

Share to:
see all

All Comments (0)

Sign In or Sign Up now to post a comment!
Loading...

Alert icon
0 / 00Unsaved Playlist Return to active list
    1. Your queue is empty. Add videos to your queue using this button:
      or sign in to load a different list.
    Loading...Loading...Saving...
    • Clear all videos from this list
    • Learn more